Data / Research funding / University Health Network
University Health Network: 11 NIH awards ($18.6M), fiscal years 2021 to 2026
University Health Network in Toronto is funded under 11 NIH awards ($18.6M) in the NIH and NSF award files, read 2026-11-03. NIH fiscal years 2021 to 2025; NSF fiscal years 2022 to 2026.
SpecStream is the live web data engine for teams and agents. It reads the NIH and NSF award files each time the agencies update them, and this page is that reading, joined to the open federal funding opportunities on Grants.gov. Ask for the awards you track by topic, organization or state and new awards arrive in your sheet, CRM, Slack or agent as the agencies publish them.
- ENZFJ8Q5KX39UEI
Awards
11 awards in the window.
| Award | Agency | Institute or division | Fiscal year | Amount in window | Start | End | Principal investigator | Source |
|---|---|---|---|---|---|---|---|---|
| North American Star Consortium | NIH | National Cancer Institute | 2021 to 2025 | $5,236,760 | April 7, 2014 | February 28, 2027 | BEDARD, PHILIPPE | reporter.nih.gov |
| Establishing Reference Values and Clinical Decision Points for Quantitative Videofluoroscopic Measures of Swallowing | NIH | National Institute on Aging | 2022 to 2025 | $3,572,615 | August 1, 2010 | July 31, 2027 | STEELE, CATRIONA MARGARET | reporter.nih.gov |
| Mechanistic investigations of microbiome-driven aryl hydrocarbon receptor activity and macrophage function in pancreatic cancer. | NIH | National Cancer Institute | 2021 to 2025 | $1,832,774 | May 1, 2021 | April 30, 2026 | MCGAHA, TRACY L | reporter.nih.gov |
| CATCH: Creating Access to Transplant for Candidates who are High Risk | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $1,592,826 | August 5, 2022 | July 31, 2027 | KESHAVJEE, SHAF | reporter.nih.gov |
| Establishing the clinical utility of cell-free tumor DNA methylation profiling as a reliable liquid biopsy approach in brain tumors | NIH | National Cancer Institute | 2022 to 2025 | $1,572,445 | April 1, 2022 | March 31, 2027 | ZADEH, GELAREH | reporter.nih.gov |
| Immunoengineering of donor lungs to optimize long-term graft function | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $1,190,652 | February 12, 2024 | December 31, 2028 | KESHAVJEE, SHAF | reporter.nih.gov |
| Defining the impact of dolutegravir on the maternal metabolic environment and its implications on risk of congenital anomalies. | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2024 | $1,164,832 | September 20, 2020 | June 30, 2026 | SERGHIDES, LENA | reporter.nih.gov |
| Understanding the molecular mechanism of a protein-recycling complex in small cell lung cancer treatment resistance. | NIH | National Cancer Institute | 2021 to 2025 | $1,151,141 | September 25, 2020 | August 31, 2026 | LOK, BENJAMIN H | reporter.nih.gov |
| Mechanisms of Viral Persistence | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $972,000 | December 1, 2009 | June 30, 2025 | BROOKS, DAVID G | reporter.nih.gov |
| A longitudinal population-based birth cohort study to understand the past, present, and future of children and youth with traumatic brain injury | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2022 | $197,714 | December 17, 2020 | May 31, 2024 | CHAN, VINCY | reporter.nih.gov |
| Sequential infection of laboratory mice for enhanced cancer and immunotherapy translation | NIH | National Cancer Institute | 2025 | $138,846 | August 1, 2025 | July 31, 2027 | BROOKS, DAVID G | reporter.nih.gov |
Funding by fiscal year
| Fiscal year | NIH awards | NIH amount | NSF awards | NSF amount |
|---|---|---|---|---|
| 2025 | 8 | $4,672,794 | 0 | $0 |
| 2024 | 8 | $4,054,719 | 0 | $0 |
| 2023 | 7 | $4,768,810 | 0 | $0 |
| 2022 | 9 | $3,559,558 | 0 | $0 |
| 2021 | 6 | $1,566,724 | 0 | $0 |
Open federal funding opportunities
From Grants.gov: notices that funded awards in this table, and open notices on the same agency and assistance listing.
| Open opportunity | Number | Agency | Listing | Closes | Award ceiling | Why it matches |
|---|---|---|---|---|---|---|
| NCI Research Specialist (Clinician Scientist) Award (R50 Clinical Trial Not Allowed) | PAR-27-089 | NIH | 93.395 | November 2, 2026 | Not listed | Same assistance listing 93.395 as 2 awards here |
| Autism Centers of Excellence R01 | RFA-HD-27-001 | NIH | 93.865 | November 2, 2026 | Not listed | Same assistance listing 93.865 as 2 awards here |
| Autism Centers of Excellence P50 | RFA-HD-27-002 | NIH | 93.865 | November 2, 2026 | Not listed | Same assistance listing 93.865 as 2 awards here |
| Infectious Diseases Clinical Trials Network (IDCTN) (UM1 Clinical Trial Required) | RFA-AI-27-002 | NIH | 93.855 | November 10, 2026 | Not listed | Same assistance listing 93.855 as 2 awards here |
| Clinical Research Network on Antimicrobial Resistance (UM1 Clinical Trial Required) | RFA-AI-27-005 | NIH | 93.855 | November 10, 2026 | Not listed | Same assistance listing 93.855 as 2 awards here |
| Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed) | RFA-CA-27-001 | NIH | 93.394 | November 10, 2026 | $150,000 | Same assistance listing 93.394 as 2 awards here |
| Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed) | RFA-CA-27-002 | NIH | 93.394 | November 10, 2026 | $300,000 | Same assistance listing 93.394 as 2 awards here |
| Precision Approaches in Radiation Synthetic Combinations (PAIRS, RP1 Clinical Trial Optional) | PAR-26-152 | NIH | 93.395 | November 11, 2026 | Not listed | Same assistance listing 93.395 as 2 awards here |
| Ethical, Legal and Social Implications (ELSI) Small Research Grant (R03 Clinical Trial Optional) | PAR-25-370 | NIH | 93.865 | November 16, 2026 | $50,000 | Same assistance listing 93.865 as 2 awards here |
| Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21 Clinical Trial Optional) | PAR-25-369 | NIH | 93.865 | November 18, 2026 | Not listed | Same assistance listing 93.865 as 2 awards here |
| Ethical, Legal and Social Implications (ELSI) Research (R01 Clinical Trial Optional) | PAR-25-371 | NIH | 93.865 | November 18, 2026 | Not listed | Same assistance listing 93.865 as 2 awards here |
| NCI Research Specialist Award for Core and Laboratory-based Scientists (R50 Clinical Trial Not Allowed) | PAR-27-088 | NIH | 93.395 | November 20, 2026 | Not listed | Same assistance listing 93.395 as 2 awards here |
| HEAL Initiative: Pain Research Enhancement Program (PREP) (R15 Clinical Trial Optional) | RFA-AT-25-003 | NIH | 93.865 | November 23, 2026 | $375,000 | Same assistance listing 93.865 as 2 awards here |
| Competing Revisions to Existing NIH Single Project Research Grants and Cooperative Agreements (Clinical Trial Optional) | PA-23-317 | NIH | 93.865 | November 24, 2026 | Not listed | Same assistance listing 93.865 as 2 awards here |
| NIH Research Software Engineer (RSE) Award (R50 Clinical Trials Not Allowed) | RFA-OD-24-011 | NIH | 93.865 | December 4, 2026 | Not listed | Same assistance listing 93.865 as 2 awards here |
| Small Business Transition Grant for New Entrepreneurs (Parent R43/R44 Clinical Trial Optional) | PAR-27-039 | NIH | 93.865 | January 5, 2027 | Not listed | Same assistance listing 93.865 as 2 awards here |
| Small Business Transition Grant for New Entrepreneurs (Parent R41/R42 Clinical Trial Optional) | PAR-27-040 | NIH | 93.865 | January 5, 2027 | Not listed | Same assistance listing 93.865 as 2 awards here |
| Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Required) | PAR-24-214 | NIH | 93.395 | January 7, 2027 | $375,000 | Same assistance listing 93.395 as 2 awards here |
| Academic-Industrial Partnerships (AIP) to Translate and Validate In Vivo Imaging Systems (R01 Clinical Trial Optional) | PAR-25-079 | NIH | 93.395 | January 7, 2027 | $500,000 | Same assistance listing 93.395 as 2 awards here |
| National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trial Required) | PAR-25-081 | NIH | 93.395 | January 7, 2027 | $499,999 | Same assistance listing 93.395 as 2 awards here |
Topics of its NIH awards
- Translational Research
- Cancer
- Rare Diseases
- Genetics
- Clinical Research
- Cancer Genomics
- Human Genome
- Biotechnology
- Lung
- Digestive Diseases
- Immunotherapy
- Orphan Drug
Updated November 3, 2026. Read from NIH RePORTER ExPORTER and NSF Award Search. Published by NIH and NSF as U.S. government data. NIH awards are fiscal years 2021 to 2025 (NIH files published to 2026-07-09); NSF awards are fiscal years 2022 to 2026 (NSF files published to 2026-11-02). NIH amounts are the total cost of each fiscal year in the window; NSF amounts are the funds obligated in the window. Organizations are matched on the UEI. Open opportunities come from Grants.gov and match on agency and assistance listing number, and on the notice number NIH prints on an award. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.